0001209191-22-056577.txt : 20221114
0001209191-22-056577.hdr.sgml : 20221114
20221114161310
ACCESSION NUMBER: 0001209191-22-056577
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20221111
FILED AS OF DATE: 20221114
DATE AS OF CHANGE: 20221114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McIlvenny Patrick
CENTRAL INDEX KEY: 0001952703
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 221385428
MAIL ADDRESS:
STREET 1: C/O HORIZON THERAPEUTICS PLC
STREET 2: 70 ST. STEPHEN'S GREEN
CITY: DUBLIN
STATE: L2
ZIP: D02 E2X4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2022-11-11
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001952703
McIlvenny Patrick
C/O HORIZON THERAPEUTICS PLC
70 ST. STEPHEN'S GREEN
DUBLIN
L2
IRELAND
0
1
0
0
Chief Accounting Officer
Ordinary Shares
2490
D
Restricted Stock Units (RSU)
Ordinary Shares
3871
D
Restricted Stock Units (RSU)
Ordinary Shares
4396
D
Restricted Stock Units (RSU)
Ordinary Shares
5713
D
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The 3,871 ordinary shares subject to the restricted stock units vest on January 5, 2023.
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 2,198 ordinary shares subject to the restricted stock units vest on January 5, 2023; and 2,198 ordinary shares subject to the restricted stock units vest on January 5, 2024.
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 1,904 ordinary shares subject to the restricted stock units vest on January 5, 2023; 1,904 ordinary shares subject to the restricted stock units vest on January 5, 2024; and 1,905 ordinary shares subject to the restricted stock units vest on January 5, 2025.
/s/ Patrick McIlvenny
2022-11-11
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Adriana Hernandez-Capone, Sean Clayton and Meghanne Downes of Horizon
Therapeutics plc (the "Company"), signing individually, the undersigned's true
and lawful attorney-in fact and agent to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each of the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect with respect to
each of the foregoing attorneys-in-fact until the earliest to occur of (a) the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
(b) revocation by the undersigned in a signed writing delivered to such
attorney-in-fact or (c) until such attorney-in-fact shall no longer be employed
by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 11th day of November, 2022.
/s/ Patrick McIlvenny